Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility.
暂无分享,去创建一个
Martin J Buxton | Timothy Niecko | M. Buxton | B. Feagan | David W. Miller | Brian G Feagan | Loretto A Lacey | David W Miller | Raymond J Townsend | L. Lacey | T. Niecko | R. Townsend
[1] M. Boyle,et al. Multiattribute and Single‐Attribute Utility Functions for the Health Utilities Index Mark 3 System , 2002, Medical care.
[2] Mark Sculpher,et al. Estimating utility data from clinical indicators for patients with stable angina , 2005, The European Journal of Health Economics.
[3] S. Targan,et al. Natalizumab induction and maintenance therapy for Crohn's disease. , 2005, The New England journal of medicine.
[4] A. Garratt,et al. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation. , 2000, Journal of clinical epidemiology.
[5] G. Guyatt,et al. A new measure of health status for clinical trials in inflammatory bowel disease. , 1989, Gastroenterology.
[6] H. König,et al. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease , 2002, European journal of gastroenterology & hepatology.
[7] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[8] M Johannesson,et al. The Relationship between Health-state Utilities and the SF-12 in a General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[10] B. Feagan,et al. An Evaluation of Utility Measurement in Crohn's Disease , 1997, Inflammatory bowel diseases.
[11] J. Brazier,et al. A comparison of the EQ-5D and SF-6D across seven patient groups. , 2004, Health economics.
[12] R. Brooks. EuroQol: the current state of play. , 1996, Health policy.
[13] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[14] Mark Oppe,et al. EQ-5D value sets : inventory, comparative review, and user guide , 2007 .
[15] M. Bala,et al. The effects of infliximab maintenance therapy on health-related quality of life. , 2003 .
[16] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[17] N. Devlin,et al. Comprar EQ-5D Value Sets: Inventory, Comparative Review and User Guide | Szende, Agota | 9781402055102 | Springer , 2007 .
[18] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[19] Mark Oppe,et al. EQ-5D Value Sets , 2007 .
[20] N. Sengupta,et al. Mapping the SF-12 to the HUI3 and VAS in a Managed Care Population , 2004, Medical care.